Evidence map›Paper›PMID 35328033›Full record

ReviewGenes2022

Does the Expression and Epigenetics of Genes Involved in Monogenic Forms of Parkinson's Disease Influence Sporadic Forms?

Aymeric Lanore, Suzanne Lesage, Louise-Laure Mariani, Poornima Jayadev Menon, Philippe Ravassard, Helene Cheval, Olga Corti, Alexis Brice, Jean-Christophe Corvol

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Aymeric LanoreInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.
Suzanne LesageInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.
Louise-Laure MarianiInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.ORCID 0000-0002-2365-1223
Poornima Jayadev MenonInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.ORCID 0000-0003-0739-3313
Philippe RavassardInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.
Helene ChevalInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.
Olga CortiInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.
Alexis BriceInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.
Jean-Christophe CorvolInstitut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, Sorbonne Université, 75013 Paris, France.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a disorder characterized by a triad of motor symptoms (akinesia, rigidity, resting tremor) related to loss of dopaminergic neurons mainly in the

Indexed as

Parkinson DiseaseDopamineDopaminergic NeuronsEpigenesis, GeneticEpigenomicsHumansDopamineDNA methylationepigeneticgenetichistone modificationneurodegenerationParkinson’s and related diseasesParkinson’s diseaseRNA-based gene regulation

Identifiers

PMID35328033
PMCPMC8951612
OpenAlexW4220771110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.